Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Acute myeloid leukaemia (AML), Blood cancers, Chronic leukaemia, Chronic myeloid leukaemia (CML), Myelodysplastic syndrome (MDS)
Open
Phase 2
This study is looking at a type of treatment called intestinal microbiota transplant. It’s a way of encouraging more variety in gut bacteria.
It’s open to people having a with donor cells for:
acute myeloid leukaemia (AML)
acute lymphoid leukaemia (ALL)
acute leukaemia of ambiguous lineage
myelodysplastic syndrome (MDS)
chronic myelomonocytic leukaemia (CMML)
chronic myeloid leukaemia (CML)
Recruitment start: 1 May 2024
Recruitment end: 1 October 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jiri Pavlu
Professor Julian Marchesi
Imperial College London
Medical Research Council (MRC)
Last reviewed: 7 May 2025
CRUK internal database number: 19681